What is the recommended treatment for Streptococcal (Strep) pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Streptococcal Pharyngitis

Penicillin or amoxicillin for 10 days remains the first-line treatment for streptococcal pharyngitis due to proven efficacy, no documented resistance, narrow spectrum, safety, and low cost. 1, 2

First-Line Antibiotic Therapy

Standard Treatment for Non-Allergic Patients

  • Penicillin V or amoxicillin for a full 10-day course is the drug of choice, with no documented penicillin resistance in Group A Streptococcus anywhere in the world 1, 2
  • Penicillin V dosing: 250 mg orally twice daily for 10 days in children; 250-500 mg twice to three times daily for 10 days in adults 1
  • Amoxicillin is equally effective and often preferred due to better palatability and twice-daily dosing 1
  • Intramuscular benzathine penicillin G is preferred when compliance with oral therapy is questionable, as it ensures complete treatment and prevents rheumatic fever 1, 3

Critical Treatment Duration

  • A full 10-day course is essential to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever 1, 2, 3
  • Shortening the course by even a few days results in appreciable increases in treatment failure rates and risk of complications 1, 2
  • The primary goal is not just symptomatic improvement but prevention of acute rheumatic fever, which requires adequate bacterial eradication 1

Treatment for Penicillin-Allergic Patients

Non-Immediate (Non-Anaphylactic) Penicillin Allergy

  • First-generation cephalosporins are the preferred first-line alternatives, with strong, high-quality evidence supporting their efficacy 1, 2
  • Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg/dose) for 10 days in children; 500 mg twice daily for 10 days in adults 2
  • Cefadroxil: 30 mg/kg once daily (maximum 1 gram) for 10 days 2
  • Cross-reactivity risk is only 0.1% in patients with non-severe, delayed penicillin reactions 2
  • Narrow-spectrum first-generation cephalosporins are strongly preferred over broad-spectrum agents (cefdinir, cefixime, cefpodoxime) due to lower cost and reduced selection for antibiotic-resistant flora 1

Immediate/Anaphylactic Penicillin Allergy

  • All beta-lactam antibiotics must be avoided due to up to 10% cross-reactivity risk in patients with immediate hypersensitivity reactions (anaphylaxis, angioedema, respiratory distress, or urticaria within 1 hour) 1, 2
  • Clindamycin is the preferred alternative with strong, moderate-quality evidence: 7 mg/kg per dose three times daily (maximum 300 mg/dose) for 10 days 1, 2
  • Clindamycin resistance is approximately 1% in the United States, making it highly reliable 1, 2
  • Clindamycin demonstrates superior efficacy in eradicating streptococci, even in chronic carriers and treatment failures 1, 2

Macrolide Alternatives (Less Preferred)

  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days—the only antibiotic requiring just 5 days due to prolonged tissue half-life 1, 2, 4
  • Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg/dose) for 10 days 1, 2
  • Erythromycin: 20-40 mg/kg/day divided 2-3 times daily (maximum 1 gram/day) for 10 days—less preferred due to high gastrointestinal side effects 1, 2
  • Critical limitation: Macrolide resistance is 5-8% in the United States and varies geographically, with some areas experiencing much higher rates 1, 2
  • Important caveat: Data establishing efficacy of azithromycin in preventing rheumatic fever are not available, unlike penicillin 4

Common Pitfalls to Avoid

  • Do not prescribe shorter courses than 10 days (except azithromycin's 5-day regimen), as this dramatically increases treatment failure and rheumatic fever risk 1, 2
  • Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to the 10% cross-reactivity risk 1, 2
  • Do not use azithromycin or macrolides as first-line therapy when penicillin can be used—reserve for documented penicillin allergy 1, 2
  • Do not use broad-spectrum cephalosporins when narrow-spectrum first-generation agents are appropriate, as they are more expensive and select for resistant flora 1
  • Do not use trimethoprim-sulfamethoxazole (Bactrim) for strep throat—it is ineffective due to high resistance rates and cannot prevent rheumatic fever 2

Adjunctive Symptomatic Therapy

  • Acetaminophen or NSAIDs (such as ibuprofen) should be considered for moderate to severe symptoms or high fever, with strong, high-quality evidence for reducing pain and inflammation 1, 2
  • Aspirin must be avoided in children due to risk of Reye syndrome 1, 2
  • Corticosteroids are not recommended as adjunctive therapy—they provide only minimal symptom reduction (approximately 5 hours) and carry potential adverse effects 1, 2

Post-Treatment Considerations

  • Routine follow-up throat cultures or rapid antigen tests are not recommended for asymptomatic patients who have completed therapy 2, 3
  • Patients are no longer contagious after 24 hours of appropriate antibiotic therapy 3
  • Clinical improvement typically occurs within 24-48 hours of starting antibiotics 3
  • Follow-up testing should only be considered in special circumstances, such as patients with a history of rheumatic fever or in outbreak situations 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment and Bacterial Clearance in Strep Throat

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.